# Nirsevimab (Genetical Recombination) I.M. Injection 50mg Syringe (ベイフォータス筋注５０ｍｇシリンジ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6250411G1022). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6250411G1022
- **Product name (Japanese):** ベイフォータス筋注５０ｍｇシリンジ
- **English title:** Nirsevimab (Genetical Recombination) I.M. Injection 50mg Syringe
- **Active ingredient:** ニルセビマブ（遺伝子組換え）
- **Active ingredient (INN):** Nirsevimab (Genetical Recombination)
- **Strength / unit:** ５０ｍｇ０．５ｍＬ１筒
- **Route:** Injection (注射薬)
- **Therapeutic category:** 62 Chemotherapeutics (化学療法剤) › 625 Antivirals (抗ウイルス剤)
- **Manufacturer:** Sanofi (サノフィ)
- **NHI price (reference only):** JPY 459147 per ５０ｍｇ０．５ｍＬ１筒
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6250411G1022
- **JSON:** https://www.nifujipharma.com/api/drugs/6250411G1022

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Nirsevimab%20(Genetical%20Recombination)%20I.M.%20Injection%2050mg%20Syringe%20(%E3%83%99%E3%82%A4%E3%83%95%E3%82%A9%E3%83%BC%E3%82%BF%E3%82%B9%E7%AD%8B%E6%B3%A8%EF%BC%95%EF%BC%90%EF%BD%8D%EF%BD%87%E3%82%B7%E3%83%AA%E3%83%B3%E3%82%B8)%20%2F%20YJ%206250411G1022#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Nirsevimab (Genetical Recombination)

- [Nirsevimab (Genetical Recombination) I.M. Injection 100mg Syringe (ベイフォータス筋注１００ｍｇシリンジ)](https://www.nifujipharma.com/drugs/6250411G2029) — １００ｍｇ１ｍＬ１筒, Sanofi